Fourthquarter - within the company labs they have the same buzz. My wife is secretary in one of the lab.
They are expecting a letter with details of what more is explanations/tests are required by FDA. Overall, the company has too much investment in the drug testing till this point to simply scrap the whole thing.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.